Patent Assignment
Reel/Frame 058712/0905
Assignment of Assignor's Interest
Recorded: 2022-01-20
Pages: 4
Assignor
CHARLES RIVER LABORATORIES, INC.
Executed: 2019-04-24
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Inhibitors of Plasma Kallikrein and Uses Thereof
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 23, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056957/0356 →
Assignment of Assignor's Interest
Jan 20, 2022
From: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
To: CHARLES RIVER LABORATORIES, INC.
Reel/Frame 058712/0889 →
Assignment of Assignor's Interest
Jan 20, 2022
From: FINK, SARAH JOCELYN
To: BIODURO LLC
Reel/Frame 058712/0920 →
Assignment of Assignor's Interest
Jan 20, 2022
From: RAE, ALASTAIR; ELLARD, JOHN MARK
To: CHARLES RIVER DISCOVERY RESEARCH SERVICES UK LIMITED
Reel/Frame 058713/0014 →
Assignment of Assignor's Interest
Jan 20, 2022
From: PAPAIOANNOU, NIKOLAOS; MILLER, THOMAS ALLEN; SHIPPS, GERALD WAYNE, JR.; TRAVINS, JEREMY MARK
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058713/0029 →
Assignment of Assignor's Interest
Jan 20, 2022
From: BIODURO LLC
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 058713/0041 →